Obesity Drug Wegovy Sales Trends Upwards: Novo Nordisk Lifts 2023 Forecast
Diabetes and obesity drug developer Novo Nordisk A/S (NYSE:NVO) raised its 2023 operating profit and sales growth expectations supported by stronger expected…
Fastenal Q1 Highlights: 9.1% Sales Growth, EPS Beat, Margin Pressure & More
Fastenal Company (NASDAQ:FAST) reported Q1 sales growth of 9.1% Y/Y to $1.859 billion, marginally missing the consensus of $1.86 billion.…
Fox News-Dominion Voting Systems’ Defamation Case: Jury Selection Begins, Trial To Start Monday
Jury selection is expected to begin today in Dominion Voting Systems’ defamation case against Fox News, a unit of Fox Corporation (NASDAQ: FOX).
Chevron Approaching Production-Sharing Deal Closure With Angola And Congo: Report
Chevron Corp (NYSE: CVX) is nearing finalizing a production-sharing deal with Angola and the Democratic Republic of Congo for operating their shared offshore oil block.
A spokesman for Chevron declined to comment on the news.
Hasbro Hires Harley-Davidson Executive To Support Blueprint 2.0 Strategy
Hasbro Inc (NASDAQ:HAS) announced two significant leadership changes on Wednesday. The leading toy maker appointed Gina Goetter as the new…
Becton Dickinson ‘Capable Of Sustaining A Breakout’, Analyst Upgrades Stock With 20% Upside Potential
KeyBanc has upgraded Becton, Dickinson, and Company (NYSE:BDX) with a price target of $304. The analyst writes that BDX is progressing toward…
This Analyst Downgrades Imperial Oil, Slashes Price Target On Gloomy Commodity Outlook
RBC Capital analyst Greg Pardy has downgraded Imperial Oil Ltd (NYSE:IMO) to Sector Perform from Outperform and cut the price target to…
ConocoPhillips Shares 10-Year Plan: Debt Reduction On Track, Capital Expenditure To Average $10B Annually
ConocoPhillips (NYSE:COP) disclosed a detailed 10-year operating and financial plan at an analyst & investor meeting. Based on a $60…
US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma
A U.S. appeals court affirmed a decision to cancel an Arbutus Biopharma Corporation (NASDAQ:ABUS) patent related to a legal fight…
FDA Issues Partial Clinical Hold On Merck Germany’s Multiple Sclerosis Study
The FDA has placed a partial clinical hold on initiating new patients on Germany’s Merck KGaA’s (OTC:MKGAF) (OTC:MKKGY) evobrutinib and patients with…